Recombinant luteinizing hormone induces increased production of ovarian follicular adiponectin in vivo: implications for enhanced insulin sensitivity
To access this article, please choose from the options below
G.G. has nothing to disclose. S.M. has nothing to disclose. A.A. has nothing to disclose. J.B.L. has nothing to disclose. E.G. has nothing to disclose.
Presented in part at the 61st Annual Meeting of the American Society for Reproductive Medicine (ASRM) and the 51st Annual Meeting of the Canadian Fertility and Andrology Society (CFAS), October 15–19, 2005, Montreal, Canada.
PII: S0015-0282(08)00246-X
doi:10.1016/j.fertnstert.2008.02.006
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

